All that Glitas is Not Gold — Musings on Pharma Marketing & Type 2 Diabetes
The second-generation glitazones Avandia® (rosiglitazone) and Actos® (pioglitazone) — once touted as breakthrough drugs that could reduce cardiovascular mortality in patients with…